TRexBio gets another $50M to bring more Treg candidates into the clinic

Bay Area startup TRexBio has bolstered its 2024 Series B with an additional $50 million to fund the biotech's clinical development in the burgeoning Treg space. The biotech, founded in 2018 by SV Health Investors ...